Skip to main content

War of words begins over Versum offer

4th March 2019

Submitted by:

Andrew Warmington

Merck KGaA has published an open letter to the shareholders of electronic chemicals producer Versum Materials after its board rejected an unsolicited offer to buy the company. Versum, which was spun off from Air Products & Chemicals in 2016, is in the process of a merger with Entegris and wishes to continue pursuing this. Merck made its offer of $48/share, giving Versum an enterprise value of about $5.9 billion, on 27 February.

Merck chairman and CEO Stefan Oschmann said that a combination “would create a deep and complementary portfolio of electronic materials, equipment and services for the semiconductor and display industries”. However, Versum responded that, “after careful review and consideration”, it had concluded that Merck’s “is not a superior proposal” and that the merger with Entegris “will create significant long-term value and is in the best interest of Versum’s shareholders”. Entegris CEO Bertrand Loy called its proposed deal “highly complementary and strategically compelling”.

The planned merger with Massachusetts-based Entegris, creating a global speciality materials player with an enterprise value of $9 billion, was unveiled in January. This is due to be completed in 2H 2019; Merck said that it was confident it could close a transaction with Versum in the same timeframe if the Versum board engages with it.

In its letter, Merck said that it was “disappointed” that the Versum board “has rejected without explanation our superior proposal” or accept “our offer to engage directly with Versum to understand the rationale for [this decision]”. It noted that the offer is a 51.7% premium to Versum’s pre-announcement price and 17.1% on the value of the Entegris stock they were being offered.

In addition, Merck said, its offer is “certain and immediate, without any of the significant ongoing integration, operational or market risks reflected in the value of the Entegris stock consideration and without the need for the achievement of synergies”. Versum’s own financial advisor, Lazard, had also concluded that the Merck offer was superior, it said.

The company added that it “has a strong reputation for innovation and has demonstrated a robust commitment to R&D spending and capital investment”. This philosophy, it said “is consistent with Versum’s culture and strength of its employees”. It would maintain Versum’s site at Tempe, Arizona, as its main hub for the combined electronic materials business in the US. News agency Bloomberg has indicated that Merck had been looking to buy Versum ever since the spin-off but was blindsided by Entegris. If it were to acquire Versum, semiconductors, which currently account for less than 20% of sales, would be about half of them. 

Helm, CAC Nantong expand partnership

Helm has reached an agreement with CAC Nantong Chemical to expand their global partnership. Under

Submitted by:

Andrew Warmington

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Sterling suite

CDMOs grow in ADCs

Reflecting the ongoing boom in the development antibody-drug conjugates (ADCs), two Western CDMOs announced expansions

Submitted by:

Andrew Warmington

Flamma Lundbeck

Flamma buys Lundbeck site

Italian CDMO Flamma has entered into an agreement to acquire Lundbeck Pharmaceuticals Italy (LuPI) from

Submitted by:

Andrew Warmington

Opening ceremony at UPM's biorefinery in Leuna

UPM opens biorefinery in Germany

UPM has inaugurated a biorefinery in Leuna, Germany, which will make up to 220,000 tonnes/year

Submitted by:

Andrew Warmington

Solenis pulp centre in Brazil

Solenis moves pulp centre

Solenis has relocated its Pulp Centre of Excellence from the US to a new facility

Submitted by:

Andrew Warmington

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Symrise facility in India

Symrise in double Asian expansion

Symrise has announced that it has opened its new Scent Creative Centre in Singapore and

Submitted by:

Andrew Warmington

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Lanxess to continue pigment production

Lanxess has reversed a decision to sell the chromium oxide pigments business at the Krefeld-Uerdingen

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

Semiconductor manufacturing

Sumitomo Chemical works with Tata

Sumitomo Chemical has signed a Memorandum of Understanding with India’s Tata Electronics to explore a

Submitted by:

Andrew Warmington

FramoChem and VanDeMark are separated

VanDeMark separation is complete

Japan’s Hodogaya Chemical has completed the previously announced acquisition of Hungarian API and intermediates producer

Submitted by:

Andrew Warmington